These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33744601)

  • 21. Nutritional interventions in patients with graft-versus-host disease.
    Seguy D; Hueso T
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):455-462. PubMed ID: 37389472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute graft versus host disease in hematopoietic stem cell alotransplant recipients.
    Krstevska S; Genadieva-Stavric S; Pivkova A; Stojanovski Z; Georgievski B; Balkanov T
    Med Arh; 2011; 65(5):260-4. PubMed ID: 22073847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology].
    Janicsák H; Masszi T; Reményi P; Ungvari GS; Gazdag G
    Ideggyogy Sz; 2023 Jan; 76(1-2):25-35. PubMed ID: 36892298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Prenc E; Pulanic D; Pucic-Bakovic M; Pezer M; Desnica L; Vrhovac R; Nemet D; Pavletic SZ
    Biochim Biophys Acta; 2016 Aug; 1860(8):1615-22. PubMed ID: 26923767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation.
    Torda A; Chong Q; Lee A; Chen S; Dodds A; Greenwood M; Larsen S; Gilroy N
    Transpl Infect Dis; 2014 Oct; 16(5):751-9. PubMed ID: 25040633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutritional interventions for liver-transplanted patients.
    Langer G; Großmann K; Fleischer S; Berg A; Grothues D; Wienke A; Behrens J; Fink A
    Cochrane Database Syst Rev; 2012 Aug; (8):CD007605. PubMed ID: 22895962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Imataki O; Nakatani S; Hasegawa T; Kondo M; Ichihashi K; Araki M; Ishida T; Kim SW; Mori S; Fukuda T; Tobinai K; Tanosaki R; Makimoto A; Takaue Y
    Am J Hematol; 2006 Oct; 81(10):747-52. PubMed ID: 16865687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.
    Pulewka K; Wolff D; Herzberg PY; Greinix H; Heussner P; Mumm FHA; von Harsdorf S; Rieger K; Hemmati P; Hochhaus A; Hilgendorf I
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1613-1619. PubMed ID: 28424902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation-An Analysis of 2 German Transplantation Centers.
    Wolff D; Bardak J; Edinger M; Klinger-Schindler U; Holler E; Lawitschka A; Schoemans H; Herr W; Kröger N; Ayuk Ayuketang F
    Front Public Health; 2020; 8():572470. PubMed ID: 33072711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation.
    Tecchio C; Cassatella MA
    Cell Mol Immunol; 2021 Apr; 18(4):905-918. PubMed ID: 33203938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
    Peric Z; Botti S; Stringer J; Krawczyk J; van der Werf S; van Biezen A; Aljurf M; Murray J; Liptrott S; Greenfield DM; Duarte RF; Ruutu T; Basak GW
    Bone Marrow Transplant; 2018 Aug; 53(8):1030-1037. PubMed ID: 29515252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial.
    Mousavi M; Hayatshahi A; Sarayani A; Hadjibabaie M; Javadi M; Torkamandi H; Gholami K; Ghavamzadeh A
    Support Care Cancer; 2013 Dec; 21(12):3441-8. PubMed ID: 23949839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood and marrow transplantation and nutritional support.
    Rzepecki P; Barzal J; Oborska S
    Support Care Cancer; 2010 May; 18 Suppl 2():S57-65. PubMed ID: 19727844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "This Graft-vs.-Host Disease Determines My Life. That's It."-A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany.
    Parisek M; Loss J; Holler E; Barata A; Weber D; Edinger M; Wolff D; Schoemans H; Herrmann A
    Front Public Health; 2021; 9():687675. PubMed ID: 34277549
    [No Abstract]   [Full Text] [Related]  

  • 35. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
    Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation.
    Ciftciler R; Goker H; Buyukasık Y; Karaagac T; Aksu S; Tekin F; Demiroglu H
    Transfus Apher Sci; 2020 Feb; 59(1):102597. PubMed ID: 31311753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation.
    Hümmert MW; Stadler M; Hambach L; Gingele S; Bredt M; Wattjes MP; Göhring G; Venturini L; Möhn N; Stangel M; Trebst C; Ganser A; Wegner F; Skripuletz T
    Sci Rep; 2021 Apr; 11(1):8527. PubMed ID: 33875720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutrition support during allogeneic stem cell transplantation: evidence versus practice.
    Andersen S; Banks M; Brown T; Weber N; Kennedy G; Bauer J
    Support Care Cancer; 2020 Nov; 28(11):5441-5447. PubMed ID: 32152764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced-intensity conditioning allogeneic stem cell transplantation in pediatric patients and subsequent supportive care.
    Barrell C; Dietzen D; Jin Z; Pinchefsky S; Petrillo K; Satwani P
    Oncol Nurs Forum; 2012 Nov; 39(6):E451-8. PubMed ID: 23107858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.